Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C

Table 1 Baseline characteristics of patients with genotypes 1, 3 and 4

Parameter	Genotype 1	Genotype 3	Genotype 4
	(n = 27)	(n = 56)1	(n = 17)
Age (yr)	41.9 ± 13.2	41.7 ± 10.9	46.3 ± 9.3
Weight (kg)	60.5 ± 12.0	63.3 ± 11.5	63.7 ± 10.8
Male number (%)2	19 (70.3%)	11 (19.7%)	11 (64.7%)
Hemoglobin (g/dL)	14.1 ± 1.6	13.8 ± 1.9	14.2 ± 1.2
White blood cell count (109/L)	6682 ± 1682	7086 ± 1886	7201 ± 1886
Neutrophils (%)	58.4 ± 8.4	56.0 ± 11.8	53.3 ± 8.0
Platelet count (103/L)	200 ± 80	199 ± 78	170 ± 50
Alanine Aminotransferase (U/L)	88.1 ± 41	127.7 ± 87.4	104.9 ± 61.1
HCV RNA log10 IU/mL	5.5 ± 1.2	5.4 ± 1.1	5.5 ± 0.9

¹Includes one patient with genotype 2;

²Value in percentage. HCV: Hepatitis C virus.